NASDAQ: AYTU
Aytu Biopharma Inc Stock Ownership - Who owns Aytu Biopharma?

Insider buying vs selling

Have Aytu Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jarrett DisbrowChief Business Officer2025-06-0916,666$1.50
$25.00kBuy
Joshua R. DisbrowChief Executive Officer2025-06-0966,666$1.50
$100.00kBuy
Joshua R. DisbrowChief Executive Officer2025-02-2815,000$1.30
$19.50kBuy

1 of 1

AYTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AYTU insiders and whales buy or sell their stock.

AYTU Shareholders

What type of owners hold Aytu Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC111.77%11,078,956$25.70MInsider
Cerecor Inc97.99%9,713,068$22.53MInsider
James B. Wiegand23.61%2,340,659$5.43MInsider
Ampio Pharmaceuticals Inc12.37%1,226,407$2.85MInsider
Christopher Brooke11.78%1,167,147$2.71MInsider
Nantahala Capital Management LLC10.96%1,086,812$2.52MInstitution
Nantahala Capital Management LLC10.96%1,086,812$2.52MInsider
Carl Dockery9.15%907,425$2.11MInsider
Stonepine Capital Management LLC8.20%812,676$1.89MInstitution
Awm Investment Company Inc6.25%619,874$1.44MInstitution

1 of 3

AYTU vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AYTU10.34%89.66%Net Buying
APUS0.23%57.97%Net Buying
TLPH9.25%90.75%Net Buying
SXTC0.56%0.00%
TXMD3.56%96.44%Net Buying

Aytu Biopharma Stock Ownership FAQ

Who owns Aytu Biopharma?

Aytu Biopharma (NASDAQ: AYTU) is owned by 34.47% institutional shareholders, 298.84% Aytu Biopharma insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Aytu Biopharma shareholder, owning 11.08M shares representing 111.77% of the company. Armistice Capital LLC's Aytu Biopharma shares are currently valued at $25.37M.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.